Title | Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV) - A potent insulin mimetic agent |
Publication Type | Journal Article |
Year of Publication | 1995 |
Authors | Caravan, P, Gelmini, L, Glover, N, Herring, FG, Li, HL, McNeill, JH, Rettig, SJ, Setyawati, IA, Shuter, E, Sun, Y, Tracey, AS, Yuen, VG, Orvig, C |
Journal | Journal of the American Chemical Society |
Volume | 117 |
Pagination | 12759-12770 |
Date Published | Dec |
Type of Article | Article |
ISBN Number | 0002-7863 |
Keywords | aluminum, DIABETIC RATS, DISSOCIATION, GLUCOSE, ISOLATED RAT ADIPOCYTES, MALTOL COMPLEX, METABOLISM, METAL CHELATE COMPLEXES, RECEPTOR KINASE, VANADYL COMPLEXES |
Abstract | {The reaction chemistry of the potent insulin-mimetic agent bis(maltolato)oxovanadium(IV) (abbreviated BMOV or VO(ma)(2)) is reported. VO(ma)(2) (log K-1 = 8.80(2), log K-2 = 7.51(2), log beta(2) = 16.31(3)) has a rich coordination chemistry, forming a number of V(IV) and V(V) derivatives. In aqueous solution it is slowly oxidized by molecular oxygen to [VO2(ma)(2)](-) (log K-1 = 7.5(1), log K-2 = 6.2(1), log beta(2) = 13.7(1)); in alcohols a variety of V(V) analogs VO(OR)(ma)(2) (R = CH3, C2H5, i-C3H7) are formed by aerial oxidation. All these vanadate complexes can be interconverted by reaction with the appropriate alcohol or water. In addition, the six-coordinate V(IV) pyridine adduct VO(ma)(2)py can be formed and this undergoes oxidation to V(V) complexes much more slowly, demonstrating that a vacant coordinate site is required for the coordination of O-2 to VO(ma)(2) before inner-sphere oxidation can take place. V-51 NMR and electrochemistry have been studied as a function of pH; a complete study of the aqueous chemistry of VO(ma)(2) and [VO2(ma)(2)](-) has been undertaken because the oral activity of VO(ma)(2) as an insulin-mimetic may be related to the chemical properties of the two compounds in water. Oral gavage studies in STZ-diabetic rats have been performed which showed that the intact complex is required for activity and that the presence of a biologically compatible reducing agent, ascorbic acid, neither interferes with nor augments the insulin-mimetic effect of VO(ma)(2). The X-ray structures of VO(ma)(2) and the cis-VO2 compound K[VO2(ma)(2)]. H2O have been determined; crystals of VO(ma)(2)[BMOV] are monoclinic, P2(1)/n |
URL | <Go to ISI>://A1995TM48300013 |